Valerie Yang, Senior Medical Oncologist at OncoCare Cancer Centre, shared on LinkedIn:
“Now that I’m home from ESMO 2026, here is my take on the relevant clinical practice-changing updates across all cancer types.
- A poster summary of positive updates to incorporate into your clinic today
- A more comprehensive summary of pan tumor trials – split into tumor type, positive and practice changing, promising not yet practice changing, and important negatives. I identified and distilled it down to 40 trials. Of course my favourite tumor types (melanoma and sarcomas among them) are flagged, although not yet practice-changing
- An overall summary of positive and pertinent negatives for What This Means In Practice right now
A summary document in point form across all 40 trials is also available, if anyone would like. I would love to hear your thoughts and if you agree with my clinical roundup of ESMO 2026!
For a brief translational research round up of ESMO 2026, see my earlier post.”
You can also read: 25 Posts Not to Miss from ESMO Congress 2026: Day 5
